Specialty / Expertise

Melanoma and Renal cancer

Research Interests

Current Research Projects

Research Staff

Training

Dr. Tykodi received his MD and PhD from Washington University, St. Louis, MO. He completed his Internal Medicine Residency at the Barnes-Jewish Hospital, Washington University, St. Louis, MO. He was a Post-Doctoral Fellow in Medical Oncology at University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Warren, E. H., N. J. Vigneron, M. A. Gavin, P. G. Coulie, V. Stroobant, A. Dalet, S. S. Tykodi, S. M. Xuereb, J. M. Mito, S. R. Riddell, and B. J. Van den Eynde. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science. 2006. 313:1444-1447.

Tykodi, S. S., E. H. Warren, J. A. Thompson, S. R. Riddell, R. W. Childs, B. E. Otterud, M. F. Leppert, R. Storb and B. M. Sandmaier. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin. Cancer Res. 2004. 10:7799-7811

Warren, E. H., S. S. Tykodi, M. Murata, B. M. Sandmaier, R. Storb, E. Jaffee, R. Childs, J. A. Thompson, P. D. Greenberg, and S. R. Riddell. T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma. Cytotherapy. 2002. 4:441

Fan, R., S. S. Tykodi, and T. J. Braciale. Recognition of a sequestered self peptide by influenza virus-specific CD8+ cytolytic T lymphocytes. J. Immunol. 2000. 164:1669-80.

Cao, W., S. S. Tykodi, M. T. Esser, V. L. Braciale, and T. J. Braciale. Partial activation of CD8+ T cells by a self-derived peptide. Nature. 1995. 378:295-8.

Walter, M. H., E. M. Westbrook, S. Tykodi, A. M. Uhm, and E. Margoliash. Crystallization of tuna ferricytochrome c at low ionic strength. J. Biol. Chem. 1990. 265:4177-80